
businessDec 19, 20221:20:16pending
Lionel Hutz on Liquidia's patent battle $LQDA
About this episode
Lionel Hutz discusses his thesis for Liquidia (LQDA) and why the thinks they are likely to win their patent battle against United Therapeutics (UTHR).
Lionel's LQDA write up: https://lionelhutz.substack.com/p/waiting-with-bated-breath-for-liquidia
Chapters
- 0:00 Intro
- 2:50 LQDA overview
- 8:05 Diving into the patent background
- 16:10 Breaking down the conflicting rulings on the '793 patent
- 19:55 Why the PTAB ruling is the most important for '793
- 21:55 What's so unique about the judge's ruling on '793
- 28:30 Why PTAB ruled the '793 patent invalid
- 37:40 LQDA's primary argument for invalidating '793
- 43:30 Discussing the expert reports around the '793 patent
- 53:30 Timeline to monetization and why delaying LQDA is so important for UTHR
- 59:00 LQDA's upside if they win
- 1:13:00 LQDA's cash runway
Get every episode summarized
Each time Yet Another Value Podcast publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Yet Another Value Podcast

UK stocks are dirt cheap. Why won't the boards act? $ZIG $CRW | Undervalued-Shar...
Yet Another Value Podcast
Sep 11, 202656:57completed

Zack Buckley on $PRTH's take private
Yet Another Value Podcast
Sep 10, 202639:21completed

$TBBB: Tiendas 3B is Mexico's Aldi. Is it too late to buy? | Fruit Tree Capital
Yet Another Value Podcast
Sep 7, 202648:44pending

$LMB: Limbach missed the data center boom. Is that the opportunity? | 1 Main Cap...
Yet Another Value Podcast
Sep 1, 202650:53pending